師資陣容：林佩瑩 老師介紹

1311
次閱讀

林 佩 瑩

助理教授

學歷中央研究院與國立陽明大學合辦 台灣國際研究生分子醫學學程 博士
研究專長內科學、胸腔腫瘤學、癌症基因學、癌症基因檢測、癌症生物學
服務電話02-2905-2862
Email148254@mail.fju.edu.tw


期刊論文
  • Lai WY, Wang JW, Huang BT, Lin EP, Yang PC. A novel TNF-a-tar-geting aptamer for TNF-a-mediated acute lung injury and acute liver fail-ure. (Co-corresponding)
  • Lin EP, Hsiao TH, Lu JY, Wong SH, Lu TP, Peck K, Takashi T, YangPC. Translating Gene Signatures into a Pathological Feature: Tumor Ne-crosis Predicts Disease Relapse in Operable and Stage I Lung Adenocar-cinoma.
  • Lin EP, Lin CH, Yang CY, Lu TP, Chang SN, Hsiao TH, Huang BT, YuCJ, Chan KA, Yang PC. Population-Based Cohort Study Reveals DistinctAssociations Between Female Lung Cancer and Breast Cancer in Taiwan.
  • Huang BT, Lai WY, Chang YC, Wang JW, Yeh SD, Lin EP, Yang PC. ACTLA-4 antagonizing DNA aptamer with antitumor effect. (Co-corre-sponding) Mol Ther Nucleic Acids. 2017;8:520-528.

  • Lin PY, Chen HY, Yu SL, Yang PC. Turning Diversity toward Precision. J Natl Cancer Inst. 2017;109:1-2.

  • Lai WY, Huang BT, Wang JW, Lin PY, Yang PC. A Novel PD-L1-tar-geting Antagonistic DNA Aptamer with Antitumor Effects. (Co-corre-sponding) Mol Ther Nucleic Acids.2016;5:e397.

  • Lin PY, Lin CH, Yang PC. Factors in Association Between ParkinsonDisease and Risk of Cancer in Taiwan-Reply. JAMA Oncology. 2016;2:145-6.Lin PY, Chang SN, Hsiao TH, Huang BT, Lin CH, Yang PC. AssociationBetween Parkinson Disease and Risk of Cancer in Taiwan. JAMA Oncology. 2015;1:633-40.Hsiao TH, Chen HI, Lu JY, Lin PY, Keller C, Comerford S, TomlinsonGE, Chen Y. Utilizing signature-score to identify oncogenic pathways ofcholangiocarcinoma. Transl Cancer Res. 2013;2:6-17.

  • Lin PY and Yang PC. Circulating miRNA signature for early diagnosis oflung cancer. EMBO Mol Med. 2011;3:436-7.Lin PY, Yu SL and Yang PC. MicroRNA in lung cancer. Br J Cancer. 2010;103:1144-8.Lin PY, Chang YC, Chen HY, Chen CH, Tsui HC, Yang PC. Tumor sizematters differently in pulmonary adenocarcinoma and squamous cell car-cinoma.Lung Cancer. 2010;67:296-300.

  • Wang CY, Wang HC, Li JM, Wang JY, Yang KC, Ho YK, Lin PY, LeeLN, Yu CJ, Yang PC, Hsueh PR. Invasive infections of Aggregatibacter(Actinobacillus) actinomycetemcomitans. J Microbiol Immunol Infect.2010;43:491-7.

  • Lin PY, Wang JY, Hsueh PR, Lee LN, Hsiao CH, Yu JC, Yang PC.Lower gastrointestinal tract tuberculosis: an important but neglected dis-ease.

  • Int J Colorectal Dis. 2009;24:1175-80.

  • Lin PY, Yu CJ, Yao M, Ku SC, Lee LN, Yang PC. A patient with bron-chiectasis presented with progressive dyspnea and an unresolved right lower lung infiltrate.Thorax. 2008;63:876, 932.

  • Lin PY, Chen JS, Ku SC, Wu MZ, Yu CJ, Yang PC. A 50-year-old manwith bilateral pulmonary tumours.Thorax. 2008;63:193, 239.

  • Lin PY, Lee TC, Liu KL, Sung CD, Lin JT, Wang HP. Nautilus-pat-terned Small Intestines. Gut. 2008;57:1073, 1082.

  • Lin PY, Shih JY, Wu MZ, Chang YT, Yang PC. Extensive GI tract in-volvement of Ewing's sarcoma/peripheral primitive neuroectodermal tu-mor in an octogenarian.Gastrointest Endosc. 2008;67:1196-8.

  • Lin PY, Kuo PH, Yu CJ, Yang PC. Long-term remission of hepatic hy-drothorax after OK-432 pleurodesis. J Thorac Cardiovasc Surg.2008;136:1367-9.

  • Lin PY, Tsai MS, Chang JH, Chen WJ, Huang CH. Gastric distension: arisk factor of pneumoperitoneum during cardiopulmonary resuscitation.

 

討論會論文
  • Lin PY, Hsiao TH, Yang PC. Tumor necrosis serves as a prognostic predictor inoperable and stage I lung adenocarcinoma.
  • Lin PY, Yang CY, Lin CH, Lu TP, Yang JC, Yu CJ, Chan KA Yang PC. HighRisk for Second Primary Lung Cancer in Taiwanese Early-Onset Female BreastCancer Patients.

  • WCLC Austria. Abstract 5966. 2016.
  • Lin EP, Yang CY, Lin CW, Huang BT, Lai WY, Tseng YT, Yang PC. PrimingPD-L1 expression by chemotherapeutic agents in non-small cell lung cancers. ASCO USA. Abstract e20087. 2017.Lin EP, Chu SK, Lu TP, Shyr Y, Horn L. BRCAness is Associated with HighTumor Mutational Burden in Lung Adenocarcinoma.

  • IASLC Targeted Therapies of Lung Can-cer Meeting. USA. 2019.

  • Lin EP, Yang PC, Shyr Y. Double primary lung cancer and breast cancer is adistinct disease entity. WCLC Spain. P2.03-58. 2019.

  • Huang BT, Lai WY, Tseng YT, Yeh CN, Lin EP, Yang PC. Identification ofnovel blood-brain barrier penetrating DNA aptamers. WCLC Spain. P2.03-41. 2019.
  • Hsu CY, Lin EP, Shyr Y. Advanced Statistical Approach Tells the Difference:Taylor-Expansion Adjustment for Survival Analyses in Immunotherapy Trials.WCLC Spain. P2.04-50. 2019.